Adaptimmune Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $37k | 281k | 0.13 |
| 2025-03-31 | $15k | 76k | 0.20 |
| 2024-12-31 | $111k | 206k | 0.54 |
| 2024-09-30 | $32k | 34k | 0.95 |
| 2024-06-30 | $218k | 223k | 0.97 |
| 2024-03-31 | $498k | 315k | 1.58 |
| 2023-12-31 | $2.7M | 3.4M | 0.79 |
| 2023-09-30 | $2.8M | 3.5M | 0.78 |
| 2023-06-30 | $3.1M | 3.4M | 0.93 |
| 2023-03-31 | $1.2M | 1.1M | 1.09 |
| 2022-12-31 | $374k | 256k | 1.46 |
| 2022-06-30 | $2.7M | 1.6M | 1.70 |
| 2022-03-31 | $3.7M | 1.8M | 2.06 |
| 2021-12-31 | $5.9M | 1.6M | 3.75 |
| 2021-09-30 | $14M | 2.8M | 5.17 |
| 2021-06-30 | $1.1M | 253k | 4.26 |
| 2021-03-31 | $14M | 2.6M | 5.32 |
| 2020-12-31 | $11M | 1.9M | 5.39 |
| 2020-09-30 | $40M | 5.0M | 7.98 |
| 2020-06-30 | $34M | 3.4M | 10.01 |
| 2020-03-31 | $5.7M | 2.1M | 2.72 |
| 2019-09-30 | $29k | 19k | 1.53 |
| 2019-06-30 | $317k | 79k | 4.03 |
| 2019-03-31 | $312k | 73k | 4.29 |
| 2018-12-31 | $268k | 47k | 5.73 |
| 2018-09-30 | $3.7M | 273k | 13.57 |
| 2018-06-30 | $1.5M | 128k | 11.87 |
| 2018-03-31 | $120k | 11k | 11.21 |
| 2017-09-30 | $683k | 83k | 8.19 |
| 2017-06-30 | $89k | 20k | 4.50 |
| 2015-09-30 | $7.8M | 655k | 11.97 |